MedAware Raises $1 Million to Bring Big Data Analytics to Medical Prescription Market
Summary
MedAware, a developer of big data analytics for the medical prescription market, announced today that it has completed a $1 million Series A financing round led by equity crowdfunding platform OurCrowd. To combat the prevalence of those errors, MedAware has developed an innovative software-based solution that combines the power of big data analytics and machine learning to save lives and reduce medical costs. "From big data and analytics to machine learning and digital communications, the company aligns perfectly with GEs vision for a healthcare industry driven by technology and built for improving lives, and we look forward to working together to help transform the medical prescription market." "We are excited about the potential for MedAware to solve the huge problem of prescription error via their impressive big data technology," said Jon Medved, founder and CEO of OurCrowd. MedAware provides innovative solutions that save lives, improve patient safety and significantly reduce healthcare costs, by identifying and preventing prescription errors in real-time.
